Skip to search formSkip to main contentSkip to account menu

Atypical hyperplasia

Known as: hyperplasia atypical 
A benign (not cancer) condition in which cells look abnormal under a microscope and are increased in number.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.
BACKGROUND The cyclooxygenase-2 (COX-2) enzyme, which is induced by inflammatory and mitogenic stimuli, plays a protumorigenic… 
2001
2001
Ultrasound‐guided mammotome vacuum biopsy for the diagnosis of impalpable breast lesions
To assess the diagnostic accuracy of ultrasound‐guided mammotome vacuum biopsy in impalpable breast lesions. 
2000
2000
Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk
A history of proliferative benign breast disease has been shown to increase the risk of developing breast carcinoma, but, to the… 
Highly Cited
1999
Highly Cited
1999
Estrogen replacement therapy in women with a history of proliferative breast disease
Little information is available regarding the invasive breast carcinoma risk associated with estrogen replacement therapy (ERT… 
1997
1997
The clinicopathological significance of K-RAS point mutation and gene amplification in endometrial cancer.
Highly Cited
1996
Highly Cited
1996
Transvaginal ultrasonography and hysteroscopy in the diagnosis of endometrial abnormalities.
1994
1994
Management of ductal carcinoma in situ with nipple discharge. Intraductal spreading of carcinoma is an unfavorable pathologic factor for breast‐conserving surgery
Background. Surgical management of ductal carcinoma in situ (DCIS) has been a controversial issue in the selection of breast… 
1984
1984
Stromal invasion in endometrial adenocarcinoma.
Highly Cited
1978
Highly Cited
1978
Endometrial lesions in uteri resected for atypical endometrial hyperplasia.
Resected uteri from a series of 48 consecutive patients with atypical endometrial hyperplasia ("carcinoma in situ") identified in… 
1966
1966
Treatment of persistent endometrial hyperplasia with progestins.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)